Upgrades:
Xylem (NYSE:XYL) was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a report released on Tuesday, Marketbeat Ratings reports. The firm presently has a $120.00 target price on the industrial products company's stock, up from their prior target price of $104.00. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 19.74% from the stock's previous close.
Several other research firms have also weighed in on XYL. StockNews.com initiated coverage on Xylem in a report on Thursday, October 5th. They issued a "hold" rating on the stock. Oppenheimer upgraded shares of Xylem from a "market perform" rating to an "outperform" rating and set a $118.00 target price for the company in a report on Thursday, October 19th. Royal Bank of Canada reduced their price target on shares of Xylem from $123.00 to $120.00 and set an "outperform" rating on the stock in a report on Wednesday, November 1st. Melius raised shares of Xylem from a "hold" rating to a "buy" rating and set a $122.00 price objective for the company in a research note on Monday, October 2nd. Finally, Seaport Res Ptn reaffirmed a "neutral" rating on shares of Xylem in a research note on Tuesday, August 29th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $118.30. Read more …
Piper Sandler upgraded shares of Celanese (NYSE:CE) from an underweight rating to a neutral rating in a research note released on Tuesday morning, MarketBeat reports. The firm currently has $135.00 price target on the basic materials company’s stock, up from their prior price target of $112.00.
CE has been the subject of a number of other reports. Citigroup increased their price target on Celanese from $130.00 to $133.00 and gave the stock a neutral rating in a report on Wednesday, October 4th. StockNews.com downgraded Celanese from a hold rating to a sell rating in a report on Wednesday, October 4th. KeyCorp increased their price target on Celanese from $149.00 to $150.00 and gave the stock an overweight rating in a report on Tuesday, October 3rd. Credit Suisse Group increased their price target on Celanese from $100.00 to $111.00 and gave the stock an underperform rating in a report on Tuesday, August 8th. Finally, Royal Bank of Canada cut their price objective on shares of Celanese from $145.00 to $142.00 and set an outperform rating on the stock in a research report on Wednesday, November 8th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Celanese currently has an average rating of Hold and an average target price of $129.06. Read more …
Oppenheimer upgraded shares of Equinix (NASDAQ:EQIX) from a market perform rating to an outperform rating in a report published on Tuesday morning, Marketbeat reports. The brokerage currently has $875.00 target price on the financial services provider’s stock.
Several other research firms have also commented on EQIX. BMO Capital Markets reduced their price objective on Equinix from $870.00 to $850.00 and set an outperform rating for the company in a research note on Thursday, October 26th. Raymond James upped their price objective on Equinix from $885.00 to $910.00 and gave the stock a strong-buy rating in a research note on Thursday, August 3rd. Morgan Stanley increased their price target on Equinix from $725.00 to $785.00 and gave the stock an equal weight rating in a research note on Friday, September 8th. Scotiabank began coverage on Equinix in a research note on Friday, October 13th. They issued a sector outperform rating and a $856.00 price target for the company. Finally, StockNews.com began coverage on Equinix in a research note on Thursday, October 5th. They issued a hold rating for the company. Seven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Equinix presently has an average rating of Moderate Buy and a consensus target price of $829.85. Read more …
Applied Materials (NASDAQ:AMAT) was upgraded by stock analysts at Redburn Atlantic from a "neutral" rating to a "buy" rating in a note issued to investors on Wednesday, Briefing.com reports. The brokerage presently has a $175.00 price target on the manufacturing equipment provider's stock. Redburn Atlantic's target price suggests a potential upside of 17.25% from the company's current price.
AMAT has been the topic of several other reports. Berenberg Bank upped their price target on Applied Materials from $150.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 18th. StockNews.com raised Applied Materials from a "hold" rating to a "buy" rating in a research report on Saturday, October 21st. The Goldman Sachs Group upped their target price on Applied Materials from $135.00 to $155.00 and gave the stock a "buy" rating in a research report on Monday, August 21st. Stifel Nicolaus upped their target price on Applied Materials from $150.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday, August 18th. Finally, Bank of America upped their target price on Applied Materials from $165.00 to $175.00 in a research report on Friday, August 18th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty-one have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $161.84. Read more ...
JPMorgan Chase & Co. upgraded shares of Clorox (NYSE:CLX) from an underweight rating to a neutral rating in a report published on Wednesday morning, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has $145.00 price objective on the stock, up from their previous price objective of $124.00.
Several other equities analysts have also recently commented on the stock. Sanford C. Bernstein raised shares of Clorox from an underperform rating to a market perform rating and set a $120.00 price target for the company in a research report on Thursday, October 12th. Jefferies Financial Group started coverage on shares of Clorox in a research report on Monday, November 13th. They issued an underperform rating and a $117.00 price target for the company. Citigroup raised shares of Clorox from a neutral rating to a buy rating and raised their price target for the company from $135.00 to $150.00 in a research report on Thursday, November 2nd. StockNews.com assumed coverage on shares of Clorox in a report on Thursday, October 5th. They issued a hold rating on the stock. Finally, UBS Group upgraded shares of Clorox from a sell rating to a neutral rating and raised their price objective for the company from $124.00 to $132.00 in a report on Monday, November 6th. Five equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox has an average rating of Hold and a consensus price target of $139.53. Read more …
Downgrades:
Morgan Stanley (NYSE:MS) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating in a research report issued on Monday, Briefing.com reports. They presently have a $85.00 price target on the financial services provider's stock. BNP Paribas' price target would suggest a potential upside of 5.88% from the company's previous close.
A number of other analysts have also recently weighed in on the company. Atlantic Securities increased their price target on Morgan Stanley from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 1st. Oppenheimer increased their price target on Morgan Stanley from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Thursday. JPMorgan Chase & Co. dropped their price target on Morgan Stanley from $93.00 to $92.00 and set an "overweight" rating on the stock in a research report on Thursday, October 5th. BMO Capital Markets dropped their price target on Morgan Stanley from $102.00 to $101.00 and set an "outperform" rating on the stock in a research report on Thursday, October 19th. Finally, Evercore ISI decreased their price objective on Morgan Stanley from $102.00 to $97.00 and set an "outperform" rating for the company in a report on Thursday, October 19th. Nine investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $94.18. Read more ...
Royal Bank of Canada cut shares of Hershey (NYSE:HSY) from an outperform rating to a sector perform rating in a research note published on Tuesday, Marketbeat reports. They currently have $213.00 price target on the stock, down from their prior price target of $239.00.
Other equities analysts have also recently issued reports about the company. Wells Fargo & Company cut their target price on Hershey from $260.00 to $240.00 and set an equal weight rating on the stock in a report on Friday, July 28th. HSBC started coverage on shares of Hershey in a research report on Friday, September 22nd. They issued a buy rating and a $248.00 price target on the stock. Barclays dropped their target price on Hershey from $265.00 to $218.00 and set an equal weight rating on the stock in a report on Thursday, October 12th. Mizuho dropped their price target on shares of Hershey from $195.00 to $180.00 and set a neutral rating on the stock in a research report on Tuesday, October 31st. Finally, Bank of America dropped their price target on shares of Hershey from $300.00 to $250.00 and set a buy rating on the stock in a research report on Tuesday, October 17th. Ten investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus target price of $246.05. Read more …
Archive of Upgrades and Downgrades
Comments
Post a Comment